NRF2 and cancer: the good, the bad and the importance of context
Open accessThe DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.
Abstract
Many studies of chemopreventive drugs have suggested that their beneficial effects on suppression of carcinogenesis and many other chronic diseases are mediated through activation of the transcription factor NFE2-related factor 2 (NRF2). More recently, genetic analyses of human tumours have indicated that NRF2 may conversely be oncogenic and cause resistance to chemotherapy. It is therefore controversial whether the activation, or alternatively the inhibition, of NRF2 is a useful strategy for the prevention or treatment of cancer. This Opinion article aims to rationalize these conflicting perspectives by critiquing the context dependence of NRF2 functions and the experimental methods behind these conflicting data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NRF2 is mutationally activated in 10–30% of different solid tumors including liver, lung, stomach, colon and other cancers and mutations typically disrupt the interaction between NRF2 and its E3 ligase KEAP1 (Kelch Like ECH Associated Protein 1) directly or by impeding KEAP1 co-factors CUL3 (Cullin 3) and CAND1 (Cullin Associated and Neddylation Dissociated 1) [2,5,6,7,8].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NRF2 is mutationally activated in 10–30% of different solid tumors including liver, lung, stomach, colon and other cancers and mutations typically disrupt the interaction between NRF2 and its E3 ligase KEAP1 (Kelch Like ECH Associated Protein 1) directly or by impeding KEAP1 co-factors CUL3 (Cullin 3) and CAND1 (Cullin Associated and Neddylation Dissociated 1) [2,5,6,7,8].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“NRF2 is activated and overexpressed in cancer to promote cancer cell survival; the cellular antioxidant system is largely regulated by NRF2 and its associated genes.30”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [30]
In the citing paper
“Furthermore, increased ROS levels facilitate the activation of HIF1α and NRF2 transcription factors, thus promoting transcriptional programs that further contribute to tumorigenesis (Bertout et al., 2008; Sporn and Liby, 2012).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Sporn and Liby, 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Niture, S. K., Jain, A. K., & Jaiswal, A. K. (2009) · Journal of Cell Science · doi:10.1242/jcs.058537 · Cited by 192
RetractedPhosphorylation and Dephosphorylation of Tyrosine 141 Regulate Stability and Degradation of INrf2
Jain, A. K., Mahajan, S., & Jaiswal, A. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709854200 · Cited by 49
RetractedHsp90 Interaction with INrf2(Keap1) Mediates Stress-induced Nrf2 Activation
Niture, S. K., & Jaiswal, A. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175802 · Cited by 41
RetractedTargeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Protein tyrosine phosphatases: from genes, to function, to disease
Tonks, N. K. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2039 · Cited by 1,677
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Cited by
Items 201–300 of 1,000
Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice
Schäfer, M., Willrodt, A., Kurinna, S., Link, A. S., Farwanah, H., Geusau, A., Gruber, F., Sorg, O., Huebner, A. J., Roop, D. R., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303281 · Cited by 98
“Genetic and pharmacological Nrf2 activation in murine keratinocytes in vivo induced severe acanthosis and hyperkeratosis strongly resembling ichthyosis in humans (Scha¨fer et al , 2012).”
Johansson, I., Monsen, V. T., Pettersen, K., Mildenberger, J., Misund, K., Kaarniranta, K., Schønberg, S., & Bjørkøy, G. (2015) · Autophagy · doi:10.1080/15548627.2015.1061170 · Cited by 103
“NFE2L2 is the main regulator of the expression of genes encoding proteins that controls cellular redox status.(58,72) Upon aging, nfe2l2-knockout mice have an increased risk of developing AMD-like phenotype,(73) emphasizing the important cytoprotective role of the cell’s endogenous antioxidative system.”
BackgroundSun, X., Wang, Q., Wang, Y., Du, L., Xu, C., & Liu, Q. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17070997 · Cited by 100
“Nrf2 is a nuclear transcription factor that protects cells by integrating cellular stress signals, directing various transcriptional programs [27], as well as involvement in various cellular processes, such as proliferation, differentiation, migration, apoptosis, and angiogenesis [28,29].”
BackgroundDysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Jung, B.-J., Yoo, H.-S., Shin, S., Park, Y., & Jeon, S. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.195 · Cited by 108
“SEGRAM would be an exciting strategy to develop selective and safe NRF2 inhibitors that warrant further intensive research. cOnflIcT Of InTeresT The authors declare no conflict of interest. acKnOwleDgMenTs This work was supported by grants from Basic Science Research Program through the National Research Foundation of…”
BackgroundPhytomedicine—Modulating oxidative stress and the tumor microenvironment for cancer therapy
Cheng, Y., Yang, C.-C., & Shyur, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.022 · Cited by 104
Wang, P., Li, C. G., Qi, Z., Cui, D., & Ding, S. (2016) · Experimental Physiology · doi:10.1113/ep085493 · Cited by 96
“It is involved in control of the cellular response to oxidative stress by decreasing the production of reactive oxygen species, and binds with oxidized transcription factors (hypoxia-inducible factor 1a, Nrf2 and p53 (Sporn & Liby, 2012).”
BackgroundKahroba, H., Shirmohamadi, M., Hejazi, M. S., & Samadi, N. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116986 · Cited by 100
Living on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target
Brandl, N., Seitz, R., Sendtner, N., Müller, M., & Gülow, K. (2025) · Antioxidants · doi:10.3390/antiox14081002 · Cited by 129
“These antioxidant genes include thioredoxin reductase 1, SOD, glutathione peroxidase, and catalase (Figure 3) [56–58].”
Venkatraman, G., Benesch, M. G. K., Tang, X., Dewald, J. W., McMullen, T. P. W., & Brindley, D. N. (2014) · The FASEB Journal · doi:10.1096/fj.14-262659 · Cited by 96
“Nrf2 transcription is elevated in cancers by oncogenic transformation, and mutations that stabilize Nrf2 are often found in various cancers [reviewed in (44)].”
BackgroundRadiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
Ferro, M., Musi, G., Marchioni, M., Maggi, M., Veccia, A., Giudice, F. D., Barone, B., Crocetto, F., Lasorsa, F. M., Antonelli, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054615 · Cited by 109
Oxidative Stress, Nrf2, and Epigenetic Modification Contribute to Anticancer Drug Resistance
Kang, K. A., & Hyun, J. W. (2017) · Toxicological Research · doi:10.5487/tr.2017.33.1.001 · Cited by 95
“Moreover, genetic analyses of human cancers revealed that Nrf2 may be oncogenic and cause resistance to chemotherapy (16).”
BackgroundShaw, P., Mondal, P., Bandyopadhyay, A., & Chattopadhyay, A. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.09.104 · Cited by 98
Cheng, Y., Wu, X., Nie, X., Wu, Y., Zhang, C., Lee, S. M., Lv, K., Leung, G., Fu, C., Zhang, J., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154407 · Cited by 96
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy
Zhuang, H., Liang, Z., Ma, G., Qureshi, A., Ran, X., Feng, C., Liu, X., Yan, X., & Shen, L. (2024) · MedComm · doi:10.1002/mco2.497 · Cited by 138
“410 Notably, there are antioxidants, such as radi-cicchioidin, resveratrol, naringenin, curcumin, and guani-dinium that are not only antioxidants, but also activators of Nrf2, a transcription factor involved in immune dysregulation, inflammation, oxidative stress, and mitochondrial dysfunction.”
Penning, T. M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00319 · Cited by 106
Margulis, K., Chiou, A. S., Aasi, S. Z., Tibshirani, R. J., Tang, J. Y., & Zare, R. N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803733115 · Cited by 93
“Previously, fumarate has been shown to inhibit chemical carcinogenesis in mouse skin (25).”
BackgroundCytoprotection “gone astray’’: Nrf2 and its role in cancer
Schäfer, H., Geismann, C., Arlt, A., & Sebens, S. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s36624 · Cited by 120
“However, the exact modalities by which Nrf2 is deregulated and thereby becomes protumorigenic are quite complex and only partially understood.(9,10) By conferring protection from oxidative stress or carcinogen-induced damage of cellular components – in particular, DNA, thereby avoiding mutational events – Nrf2 primari…”
Targeting IDH1-Mutated Malignancies with NRF2 Blockade
Liu, Y., Lu, Y., Celiku, O., Li, A., Wu, Q., Zhou, Y., & Yang, C. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy230 · Cited by 92
“NRF2 exhibits both oncogenic and tumor-suppressing roles in the context of cancer biology, therapy resistance, and microenvironment remodeling (23,24).”
BackgroundJeddi, F., Soozangar, N., Sadeghi, M. R., Somi, M. H., & Samadi, N. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.03.008 · Cited by 92
Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
Zavattari, P., Perra, A., Menegon, S., Kowalik, M. A., Petrelli, A., Angioni, M. M., Follenzi, A., Quagliata, L., Ledda‐Columbano, G. M., Terracciano, L., et al. (2015) · Hepatology · doi:10.1002/hep.27790 · Cited by 88
“However, as pointed out by Sporn and Liby, whether NRF2 plays a pro- or an antitumorigenic role in premalignant lesions or early malignancy is still unclear.(2) Indeed, while, on the one hand, NRF2 can protect normal cells from oxidative stress and DNA-damaging electrophiles, on the other hand, it can confer cytoprote…”
BackgroundFabrizio, F. P., Costantini, M., Copetti, M., la Torre, A., Sparaneo, A., Fontana, A., Poeta, L., Gallucci, M., Sentinelli, S., Graziano, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14492 · Cited by 87
Bose, C., Awasthi, S., Sharma, R., Beneš, H., Hauer‐Jensen, M., Boerma, M., & Singh, S. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193918 · Cited by 95
Cheng, L., Yan, B., Chen, K., Jiang, Z., Zhou, C., Cao, J., Qian, W., Li, J., Sun, L., Ma, J., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9482018 · Cited by 95
“Some researchers postulate that its precise role is dependent on the stage of tumorigenesis [25, 26], which leads to the question of whether Nrf2 should be targeted for anticancer therapeutic approaches.”
Kelch-like proteins: Physiological functions and relationships with diseases
Shi, X., Xiang, S., Cao, J., Zhu, H., Yang, B., He, Q., & Ying, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104404 · Cited by 101
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Glorieux, C., Enriquez-Lara, C., González, C. D., Aguirre-Martínez, G. V., & Calderón, P. B. (2024) · Antioxidants · doi:10.3390/antiox13010070 · Cited by 103
“While NRF2 activation has been regarded as an intriguing therapeutic approach to enhance cellular defenses against external threats, it is important to acknowledge that such activation can also promote pro-oncogenic signaling, contingent upon the context in which NRF2 is activated [91,104,213].”
BackgroundNrf2 Mutagenic Activation Drives Hepatocarcinogenesis
Ngo, H. K. C., Kim, D.-H., Cha, Y.-N., Na, H.-K., & Surh, Y.-J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3538 · Cited by 87
“20 Discussion Nrf2, the master regulator of cellular redox status is now being put at the heart of debate over its dual roles as a tumor suppressor and an oncogenic factor (34).”
BackgroundKeap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer
Chen, F., Xiao, M., Hu, S., & Wang, M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1381467 · Cited by 114
Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy
Jia, X., Wang, Y., Qiao, Y., Jiang, X., & Li, J. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00404c · Cited by 91
Li, Y., Huang, Y., Piao, Y., Nagaoka, K., Watanabe, G., Taya, K., & Li, C. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-23 · Cited by 92
“Nuclear factor erythroid 2-related factor 2 (Nrf2), a Cap'n'Collar basic leucine zipper transcription factor, plays an important role in preventing the development of oxidative stress through up-regulation of the Nrf2related antioxidants [8,9].”
BackgroundLi, K.-R., Yang, S., Gong, Y.-Q., Yang, H., Li, X., Zhao, Y., Yao, J., Jiang, Q. L., & Cao, C. (2016) · Scientific Reports · doi:10.1038/srep25525 · Cited by 86
Shah, S. Z. A., Zhao, D., Hussain, T. A., Sabir, N., Mangi, M. H., & Yang, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00310 · Cited by 92
“The degradation of Keap1 depending on p62 is another method of the NRF2 pathway activation and cell protection (Taguchi et al., 2012).”
Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation
Gong, M., Li, Y., Ye, X., Zhang, L., Wang, Z., Xu, X., Shen, Y., & Zheng, C. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00568-z · Cited by 86
Brahma, M. K., Gilglioni, E. H., Zhou, L., Trépo, E., Chen, P., & Gurzov, E. N. (2021) · Oncogene · doi:10.1038/s41388-021-01950-y · Cited by 94
“For example, somatic mutations activating nuclear factor erythroid 2-related factor-2 (NFE2L2) or inactivating Kelchlike ECH-associated protein 1 (KEAP1) have been reported in 5 to 15% of HCC [34, 35].”
BackgroundModulation of redox homeostasis: A strategy to overcome cancer drug resistance
Yang, L., Zhang, X., Wang, Z., Li, B., & Zhu, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1156538 · Cited by 116
“ROS can act as a double-edged sword: In normal cells, the activation of ROS signaling can reduce the possibility of the formation of cancerous lesions; but its abnormal activation in precancerous cells with high levels of ROS may benefit cancer cell survival (Hayes and McMahon, 2006; Lau et al., 2008; Wang et al., 200…”
BackgroundTargeting oxidative stress-mediated regulated cell death as a vulnerability in cancer
Chen, D., Guo, Z., Yao, L., Sun, Y., Dian, Y., Zhao, D., Ke, Y., Zeng, F., Zhang, C., Deng, G., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103686 · Cited by 106
“NRF2 is a master transcription factor involved in regulating antioxidant and detoxification responses [146].”
Gu, D., Lu, P., Zhang, K., Wang, X., Sun, M., Guo-qian, C., & Wang, Q. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.002 · Cited by 85
Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus
Fu, J., Xiong, Z., Huang, C. D., Li, J., Yang, W., Han, Y., Paiboonrungruan, C., Major, M. B., Chen, K., Kang, X., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005963 · Cited by 86
Therapeutic and biological activities of berberine: The involvement of Nrf2 signaling pathway
Ashrafizadeh, M., Fekri, H. S., Ahmadi, Z., Farkhondeh, T., & Samarghandian, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29392 · Cited by 91
“As a result, the keap1‐Nrf2 complex is disrupted and high concentrations of Nrf2 accumulate in the cytoplasm that translocates to the nucleus where Nrf2 triggers the cytoprotective events such as antioxidant enzymes, phase II detoxification enzymes, molecular chaperons, and anti‐inflammatory by binding to the ARE of a…”
BackgroundXu, J.-C., Chen, T., Liao, L.-T., Chen, T., Li, Q., Xu, J., Hu, J., Zhou, P., & Zhang, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.53795 · Cited by 85
“Recently, more and more analyses have indicated that Nrf2 can promote oncogenesis [31].”
BackgroundEpigenetic DNA Methylation of Antioxidative Stress Regulator NRF2 in Human Prostate Cancer
Khor, T. O., Fuentes, F., Shu, L., Paredes‐Gonzalez, X., Yang, Y., Liu, Y., Smiraglia, D. J., Yegnasubramanian, S., Nelson, W. G., & Kong, A. T. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0127 · Cited by 103
“cancer tissues, including lung, esophagus, larynx, gallbladder, skin, pancreas, ovary, and breast (37, 38).”
Köhler, U. A., Kurinna, S., Schwitter, D., Marti, A., Schäfer, M., Hellerbrand, C., Speicher, T., & Werner, S. (2014) · Hepatology · doi:10.1002/hep.26964 · Cited by 84
“Moreover, Nrf2 activation by various compounds mediated chemopreventive and anti-inflammatory effects in animal models of cancer, and some of these components are in clinical trials for cancer prevention.(7) In the liver, lack of Nrf2 aggravated damage induced by various toxins, whereas genetic activation of Nrf2, thr…”
BackgroundTargeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer
Roh, J., Jang, H.-J., Kim, E. H., & Shin, D. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6841 · Cited by 88
“Nrf2 is the central player regulating the expression of antioxidant molecules in cells (29).”
Update on the bioavailability and chemopreventative mechanisms of dietary chlorophyll derivatives
Hayes, M., & Ferruzzi, M. G. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.06.010 · Cited by 98
Bono, S., Feligioni, M., & Corbo, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00479-8 · Cited by 90
Lippmann, D., Lehmann, C., Florian, S., Barknowitz, G., Haack, M., Mewis, I., Wiesner‐Reinhold, M., Schreiner, M., Glatt, H. R., Brigelius‐Flohé, R., et al. (2014) · Food & Function · doi:10.1039/c3fo60676g · Cited by 83
Reversal of myofibroblast differentiation: A review
Yang, X., Chen, B., Liu, T., & Chen, X. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.04.007 · Cited by 90
Gacesa, R., Lawrence, K. P., Georgakopoulos, N. D., Yabe, K., Dunlap, W. C., Barlow, D. J., Wells, G., Young, A. R., & Long, P. F. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.020 · Cited by 82
Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
DeBlasi, J. M., & DeNicola, G. M. (2020) · Cancers · doi:10.3390/cancers12103023 · Cited by 86
“In healthy cells, activation of NRF2 promotes the transcription of anti-inflammatory and an ioxidant genes that suppress the de elopment of DNA damage and mutations that can initi te tumor formation [9].”
BackgroundA novel Nrf2-miR-29-desmocollin-2 axis regulates desmosome function in keratinocytes
Kurinna, S. M., Schäfer, M., Ostano, P., Karouzakis, E., Chiorino, G., Bloch, W., Bachmann, A., Gay, S., Garrod, D. R., Lefort, K., et al. (2014) · Nature Communications · doi:10.1038/ncomms6099 · Cited by 85
4-Hydroxynonenal metabolites and adducts in pre-carcinogenic conditions and cancer
Guéraud, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.025 · Cited by 90
SC79 protects retinal pigment epithelium cells from UV radiation via activating Akt-Nrf2 signaling
Gong, Y.-Q., Huang, W., Li, K., Liu, Y.-Y., Cao, G.-F., Cao, C., & Jiang, Q. L. (2016) · Oncotarget · doi:10.18632/oncotarget.11164 · Cited by 81
“com/oncotarget binds to antioxidant-responsive element (ARE), causing transcription of several key anti-oxidant genes, including heme oxygenase-1 (HO-1) and NAD(P)H: quinone oxidoreductase (NQO-1) as well asγ-glutamyl cystine ligase catalytic subunit (GCLC) and γ-glutamyl cystine ligase modifying subunit (GCLM) [16].”
BackgroundInfluentialDetection of PIWI and piRNAs in the mitochondria of mammalian cancer cells
Kwon, C.-H., Tak, H., Rho, M., Chang, H. R., Kim, Y. H., Kim, K. T., Balch, C., Lee, E. K., & Nam, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.112 · Cited by 86
Chen, F., Wang, H., Zhu, J., Zhao, R., Xue, P., Zhang, Q., Nelson, M. B., Qu, W., Feng, B., & Pi, J. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.317 · Cited by 81
“These somatic mutations alter the interaction between KEAP1 and NRF2 and result in persistent activation of NRF2 (Sporn and Liby, 2012; Ganan-Gomez et al, 2013).”
BackgroundDetection of Hydrogen Peroxide with Fluorescent Dyes
Rezende, F., Brandes, R. P., & Schröder, K. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7401 · Cited by 83
“Another example is the oxidation of cysteines in Kelch-like erythroid cell-derived protein with cap ‘n’ collar homology-associated protein 1 (KEAP-1) (129).”
Novel insights into redox system and the mechanism of redox regulation
Wang, X., & Hai, C. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-4022-y · Cited by 87
“In the nucleus, Nrf2 forms a complex with Maf proteins [152], as well as other bZIP proteins, binds to response elements on DNA, known as antioxidant response elements (AREs) or electrophile response elements (EpREs) and regulates the expression of more than 100 genes involved in the response to cellular stress [5, 15…”
BackgroundWang, Y., Tang, B., Li, H., Zheng, J., Zhang, C., Yang, Z., Tan, X., Luo, P., Ma, L., Wang, Y., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104480 · Cited by 83
“Then the cell lysates were incubated with PBS or IR-61 for 20 min at room temperature and were divided into smaller aliquots and heated individually at different temperatures (37, 40, 43, 46, 49, 52 ◦ C) for 3 min followed by cooling for 3 min at room temperature.”
Silva-Pinto, P. A., de Pontes, J. T. C., Aguilar‐Morón, B., Canales, C. S. C., Pavan, F. R., & Roque‐Borda, C. A. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42682 · Cited by 102
Benefits and Risks of the Hormetic Effects of Dietary Isothiocyanates on Cancer Prevention
Bao, Y., Wang, W., Zhou, Z., & Sun, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114764 · Cited by 90
“Over the last decade, many Nrf2 inducers i ncluding ITCs, resveratrol, catechin, cucurmin, and quercetin have been reported [67,68] with both chemopreventive and oncogenic activities [69-71].”
BackgroundWang, H., Liu, X., Yan, X., Fan, J., Li, D., Ren, J., & Qu, X. (2022) · Chemical Science · doi:10.1039/d1sc07073h · Cited by 80
“17,18 Thus, the Nrf2 antioxidant system can represent a promising target to improve the SDT e ffi cacy.”
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
Kim, E. H., Jang, H., Shin, D., Baek, S. H., & Roh, J.-L. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1284-8 · Cited by 77
Regulation of Wound Healing by the NRF2 Transcription Factor—More Than Cytoprotection
Hiebert, P., & Werner, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163856 · Cited by 90
“This is also evident when considering the potential benefits of NRF2 on wound healing, actions which may prove unwelcome during tumorigenesis [27,68].”
BackgroundInfluentialVassalle, C., Maltinti, M., & Sabatino, L. (2020) · Molecules · doi:10.3390/molecules25112653 · Cited by 80
“Accordingly, whether the Nrf2/Keap1 system i protective, its overactivation can be adverse, as in cancer and in resistance to chemoth rapy [8].”
BackgroundEpigenetic impact of dietary isothiocyanates in cancer chemoprevention
Gerhäuser, C. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328362014e · Cited by 77
Control of SUMO and Ubiquitin by ROS: Signaling and disease implications
Stankovic‐Valentin, N., & Melchior, F. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.002 · Cited by 81
The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance
Sadeghi, M. R., Jeddi, F., Soozangar, N., Somi, M. H., & Samadi, N. (2017) · Tumor Biology · doi:10.1177/1010428317705510 · Cited by 77
Zhang, X., Dong, Z., Fan, H. J., Yang, Q., Yu, G., Pan, E., He, N., Li, X., Zhao, P., Fu, M., et al. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200612 · Cited by 83
“To eliminate excessive ROS, antioxidant enzymes such as superoxide dismutase (SOD) will be largely depleted (Itoh et al., 1997; Sporn and Liby, 2012; Iranshahy et al., 2018).”
BackgroundRegulation of Keap1–Nrf2 signaling: The role of epigenetics
Cheng, D., Wu, R., Guo, Y., & Kong, A. T. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.008 · Cited by 75
“This suggests that context is important in terms of what role DNA methylation plays in Nrf2 and that similar methylation patterns may have different meanings [4,10].”
Sulfur metabolism and its contribution to malignancy
Ward, N. P., & DeNicola, G. M. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.05.001 · Cited by 84
Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment
Kumar, H., Kumar, R. M., Bhattacharjee, D., Somanna, P., & Jain, V. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.720076 · Cited by 87
“Nrf2 overexpression in the protein–protein interaction region compromised the Keap1 checkpoint, resulting in epigenetic and posttranscriptional modification and enhancing proto-oncogenes (Sporn and Liby, 2012).”
BackgroundKavitha, K., Thiyagarajan, P., Nandhini, J. R., Mishra, R., & Nagini, S. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.004 · Cited by 74
Wijdeven, R. H. M., Pang, B., van der Zanden, S. Y., Qiao, X., Blomen, V. A., Hoogstraat, M., Lips, E. H., Janssen, L., Wessels, L. F. A., Brummelkamp, T. R., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0380 · Cited by 80
T-REX on-demand redox targeting in live cells
Parvez, S., Long, M. J. C., Lin, H., Zhao, Y., Haegele, J. A., Pham, V. N., Lee, D. K., & Aye, Y. (2016) · Nature Protocols · doi:10.1038/nprot.2016.114 · Cited by 77
Dual Roles of Oxidative Stress in Metal Carcinogenesis
Xu, J., Wise, J. T. F., Wang, L., Schumann, K., Zhang, Z., & Shi, X. (2017) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2017025229 · Cited by 82
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
Cucarull, B., Tutusaus, A., Rider, P., Hernáez-Alsina, T., Cuño-Gómiz, C., de Frutos, P. G., Colell, A., Marí, M., & Morales, A. (2022) · Cancers · doi:10.3390/cancers14030621 · Cited by 82
“Oxidative stress signaling pathway is also activated through activating mutations in nuclear factor erythroid 2-related factor 2 (NFE2L2 or NFR2) or the inactivation of Kelchlike ECH-associated protein 1 (KEAP1) [21].”
BackgroundSystematic discovery of mutation-directed neo-protein-protein interactions in cancer
Mo, X., Niu, Q., Ivanov, A. A., Tsang, Y. H., Tang, C., Shu, C., Li, Q., Qian, K., Wahafu, A., Doyle, S. P., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.014 · Cited by 77
Liu, L., Shang, Y., Li, M., Han, X., Wang, J., & Wang, J. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12384 · Cited by 81
The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review
González-Donquiles, C., Alonso-Molero, J., Fernández‐Villa, T., Vilorio-Marqués, L., Molina, A. J., & Martín, V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177549 · Cited by 72
The Impact of miRNA-Based Molecular Diagnostics and Treatment of NRF2-Stabilized Tumors
Yamamoto, S., Inoue, J., Kawano, T., Kozaki, K., Omura, K., & Inazawa, J. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0246-t · Cited by 75
“These findings suggest the importance of choosing a therapeutic approach in a cellular context-dependent manner according to NRF2 status (38, 39).”
BackgroundRegulation of cell signaling pathways by dietary agents for cancer prevention and treatment
Pandey, M. K., Gupta, S. C., Nabavizadeh, A., & Aggarwal, B. B. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.002 · Cited by 76
Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
Yang, J., Xu, J., Zhang, B., Tan, Z., Meng, Q., Hua, J., Liu, J., Wang, W., Shi, S., Yu, X., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010944 · Cited by 73
Hu, Y., Guo, N., Yang, T., Yan, J., Wang, W., & Li, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1458143 · Cited by 83
“In addition, Nrf2 is a major factor that regulates intracellular redox balance in the cell [91].”
Autophagy in the “inflammation-carcinogenesis” pathway of liver and HCC immunotherapy
Yu, S., Wang, Y., Li, J., Claret, F. X., Li, Q., Tian, T., Liang, X., Ruan, Z., Jiang, L., Yao, Y., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.049 · Cited by 74
Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
Zhao, J., Lin, X., Meng, D., Zeng, L., Zhuang, R., Huang, S., Lv, W., & Hu, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578315 · Cited by 69
Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment
Zhang, J., Xu, H., Zhu, J., Dou, Y., Xian, Y., & Lin, Z. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82401 · Cited by 81
“Moreover, overexpression of Nrf2 has been linked to poor prognosis and resistance to chemotherapy in several types of cancer [46].”
BackgroundMartínez, V. D., Vucic, E. A., Thu, K. L., Pikor, L. A., Lam, S. C., & Lam, W. L. (2014) · Head & Neck · doi:10.1002/hed.23663 · Cited by 76
“Constitutive activation of the NRF2 pathway through disruption of key inhibitors is of increasingly recognized importance in tumorigenesis and chemoresistance for multiple cancers.(15,24) Given the correlation between activation of NRF2, poor patient survival, and chemotherapy resistance in HNSCC, there exists strong…”
BackgroundShen, H., Yang, Y. P., Xia, S., Rao, B., Zhang, J., & Wang, J. (2013) · Diseases of the Esophagus · doi:10.1111/dote.12124 · Cited by 79
Liu, Y., Chen, F., Wang, S., Guo, X., Shi, P., Wang, W., & Xu, B. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.467 · Cited by 69
“Nrf2 is a transcription factor that activates antioxidant response and reduces ROS.13 Decrease of Nrf2 might enhance the cytotoxicity of drugs to cancer cells.”
BackgroundInfluentialRajendran, P., Dashwood, W.-M., Li, L., Kang, Y., Kim, E., Johnson, G., Fischer, K. A., Löhr, C. V., Williams, D. E., Ho, E., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0132-y · Cited by 70
“cons of Nrf2 signaling in different stages of cancer development [17, 36].”
BackgroundSena, P., Mancini, S., Benincasa, M., Mariani, F., Palumbo, C., & Roncucci, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051478 · Cited by 79
“The identification of a ‘dark side’ of NRF-2 [36,37] has generated controversy because it is still unclear whether NRF-2 acts as a tumor suppressor or as an oncogene [36,38].”
BackgroundNRF2 signalling pathway: New insights and progress in the field of wound healing
Liu, Y., Yang, X., Liu, Y., Jiang, T., Ren, S., Chen, J., Xiong, H., Yuan, M., Li, W., Machens, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16597 · Cited by 76
Shah, N., Zaitseva, L., Bowles, K. M., MacEwan, D. J., & Rushworth, S. A. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.152 · Cited by 73
“In AML, miR-29B downregulation has been found to be associated with high C-MYC levels aswell as high SP1 and NF-κB.33,34 Furthermore, NF-κB, JUN and C-MYC have been linked to increased NRF2 activity in human cancer (including AML)10,35 and NRF2 has been shown to transcriptionally regulate miR-125B in kidney epithelia…”
BackgroundThe Role of Antioxidants in Cancer, Friends or Foes?
Poljsak, B., & Milisav, I. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190123112647 · Cited by 67
Flavonoids targeting NRF2 in neurodegenerative disorders
Khan, H. Z., Tundis, R., Ullah, H., Aschner, M., Belwal, T., Mirzaei, H., & Akkol, E. K. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111817 · Cited by 72
Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair
Qin, S., He, X., Lin, H., Schulte, B. A., Zhao, M., Tew, K. D., & Wang, G. Y. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.006 · Cited by 73
Wang, S., Tsai, K., Chou, W.-C., Cheng, H., Huang, Y., Ou, H., & Chang, Y. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500537 · Cited by 73
NRF2 and Mitochondrial Function in Cancer and Cancer Stem Cells
Panieri, E., Pinho, S., Afonso, G. J. M., Oliveira, P. J., Cunha‐Oliveira, T., & Saso, L. (2022) · Cells · doi:10.3390/cells11152401 · Cited by 75
Culletta, G., Buttari, B., Arese, M., Brogi, S., Almerico, A. M., Saso, L., & Tutone, M. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116355 · Cited by 81
Probst, B., Lyndsey, M., Isaac, T., Wigley, W. C., & Ferguson, D. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135257 · Cited by 74
“RTA 405 inhibits growth and survival equivalently in cells with different basal NRF2 activity The increase in proliferation and survival observed in MEFs derived from Keap1 mice has been proposed to be the result of high NRF2 activity [30;31].”
BackgroundInfluentialKawahara, B., Moller, T., Hu-Moore, K., Carrington, S. J., Faull, K. F., Sen, S., & Mascharak, P. K. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00476 · Cited by 72
Chen, X., Jiang, Z., Zhou, C., Chen, K., Li, X., Wang, Z., Wu, Z., Ma, J., Ma, Q., & Duan, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494547 · Cited by 71
Metadata
- Authors
- Sporn, M. B., & Liby, K. T.
- Affiliations
- Dartmouth College (US)
- Corresponding author
- Sporn, Michael B.
- Liby, Karen T.
- ORCID
- Liby, Karen T.
- Venue
- Nature Reviews Cancer
- Published
- 2012-07-19
- Volume
- 12
- Issue
- 8
- Pages
- 564-571
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3836441
- OpenAlex
- W2030749349
- Cited by
- 1,067
- References
- 120
- Citations by year
- 2026: 36 · 2025: 48 · 2024: 70 · 2023: 72 · 2022: 88 · 2021: 90 · 2020: 97 · 2019: 93 · 2018: 112 · 2017: 88 · 2016: 93 · 2015: 62 · 2014: 57 · 2013: 50 · 2012: 11
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA078814, P30CA023108)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, chemoprevention, carcinogenesis, chemoresistance, transcription factor activation
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Humans, Neoplasms, Anticarcinogenic Agents, Tumor Suppressor Proteins, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.